FDA Approved: BACLOFEN — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for baclofen from Chartwell RX, LLC, under ANDA077241, indicating regulatory approval of this supplemental submission fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Spasticity
• Spinal Cord Injury

Drugs mentioned

• BACLOFEN (Baclofen)

Snippet

SUPPL AP for BACLOFEN (BACLOFEN)